VAN NOSTRAND ROBERT L
Insider CIK 1225198 · ACHN Director · MBLX Director · SLS Director · ENUM Director · ITCI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLS SELLAS Life Sciences Group | A Award | 2026-01-07 | 2026-01-09 | 50,000 | — | $0 | 82,900 | SEC↗ |
| SLS SELLAS Life Sciences Group | P Buy | 2025-06-12 | 2025-06-13 | 10,000 | $1.48 | $14.8K | 20,400 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 4,322 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 7,009 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 2,951 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 16,757 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer deriv | 2025-04-02 | 2025-04-02 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | D To issuer | 2025-04-02 | 2025-04-02 | 11,340 | $132.00 | $1.50M | 0 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2025-01-10 | 2025-01-14 | 18,500 | — | $0 | 18,500 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2025-01-10 | 2025-01-14 | 12,500 | — | $0 | 22,900 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2024-06-28 | 2024-07-02 | 83 | $68.49 | $5.7K | 11,340 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-06-23 | 2024-06-25 | 1,567 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-06-23 | 2024-06-25 | 1,567 | — | $0 | 11,257 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-06-18 | 2024-06-21 | 8,891 | $75.71 | $673.1K | 20,799 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-06-18 | 2024-06-21 | 11,109 | $76.07 | $845.1K | 9,690 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-06-18 | 2024-06-21 | 20,000 | $16.86 | $337.2K | 29,690 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2024-06-14 | 2024-06-18 | 4,322 | — | $0 | 4,322 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2024-06-14 | 2024-06-18 | 2,951 | — | $0 | 2,951 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2024-03-31 | 2024-04-02 | 79 | $69.20 | $5.5K | 9,690 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award | 2024-03-28 | 2024-04-01 | 11,924 | — | $0 | 48,635 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2024-02-27 | 2024-02-28 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-27 | 2024-02-28 | 10,349 | $73.14 | $756.9K | 9,611 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2024-02-27 | 2024-02-28 | 9,651 | $72.71 | $701.7K | 19,960 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2024-02-27 | 2024-02-28 | 20,000 | $18.56 | $371.2K | 29,611 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2024-01-22 | 2024-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2024-01-22 | 2024-01-25 | 6,000 | — | $0 | 10,400 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2023-12-31 | 2024-01-03 | 76 | $71.62 | $5.4K | 9,611 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award | 2023-12-29 | 2024-01-03 | 18,879 | — | $0 | 36,711 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2023-09-30 | 2023-10-02 | 105 | $52.09 | $5.5K | 9,535 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award | 2023-09-29 | 2023-10-02 | 13,868 | — | $0 | 17,832 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award | 2023-06-30 | 2023-07-05 | 2,040 | — | $0 | 3,964 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2023-06-30 | 2023-07-05 | 85 | $63.32 | $5.4K | 9,430 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2023-06-23 | 2023-06-27 | 7,009 | — | $0 | 7,009 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2023-06-23 | 2023-06-27 | 1,567 | — | $0 | 1,567 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2023-05-25 | 2023-05-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2023-04-17 | 2023-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2023-04-17 | 2023-04-19 | 10,000 | $63.00 | $630.0K | 9,345 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2023-04-17 | 2023-04-19 | 10,000 | $13.05 | $130.5K | 19,345 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2023-03-31 | 2023-04-04 | 95 | $54.15 | $5.1K | 9,345 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award | 2023-03-31 | 2023-04-04 | 1,642 | — | $0 | 1,924 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2023-02-02 | 2023-02-03 | 9,500 | — | $0 | 9,500 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2023-02-02 | 2023-02-03 | 2,500 | — | $0 | 4,400 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2022-12-31 | 2023-01-04 | 2,109 | $1.58 | $3.3K | 2,109 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2022-12-30 | 2023-01-03 | 97 | $52.92 | $5.1K | 9,250 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2022-09-30 | 2022-10-03 | 1,601 | $2.83 | $4.5K | 1,601 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2022-09-30 | 2022-10-05 | 110 | $46.53 | $5.1K | 9,153 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-08-11 | 2022-08-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise deriv | 2022-08-11 | 2022-08-12 | 20,000 | — | $0 | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-08-11 | 2022-08-12 | 28,500 | $57.15 | $1.63M | 10,543 | SEC↗ |
| ITCI Intra-Cellular Therapies, | S Sale | 2022-08-11 | 2022-08-12 | 1,500 | $56.80 | $85.2K | 9,043 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-08-11 | 2022-08-12 | 20,000 | $12.45 | $249.0K | 29,043 | SEC↗ |
| ITCI Intra-Cellular Therapies, | M Exercise | 2022-08-11 | 2022-08-12 | 10,000 | $13.05 | $130.5K | 39,043 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2022-06-30 | 2022-07-01 | 2,134 | $2.12 | $4.5K | 2,134 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2022-06-30 | 2022-07-05 | 108 | $57.08 | $6.2K | 9,043 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2022-06-09 | 2022-06-13 | 16,757 | — | $0 | 16,757 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2022-05-25 | 2022-05-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2022-03-31 | 2022-04-04 | 908 | $4.99 | $4.5K | 908 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2022-03-31 | 2022-04-04 | 126 | $61.19 | $7.7K | 8,935 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2022-01-31 | 2022-02-01 | 7,125 | — | $0 | 7,125 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2022-01-31 | 2022-02-01 | 1,900 | — | $0 | 1,900 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2021-12-31 | 2022-01-03 | 976 | $4.64 | $4.5K | 976 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2021-12-31 | 2022-01-04 | 148 | $52.34 | $7.7K | 8,809 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2021-09-30 | 2021-10-04 | 801 | $5.66 | $4.5K | 801 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2021-09-30 | 2021-10-04 | 215 | $37.28 | $8.0K | 8,661 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2021-06-30 | 2021-07-01 | 562 | $8.06 | $4.5K | 562 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2021-06-30 | 2021-07-02 | 173 | $40.82 | $7.1K | 8,446 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2021-06-21 | 2021-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2021-05-24 | 2021-05-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2021-03-31 | 2021-04-02 | 383 | $11.84 | $4.5K | 383 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2021-03-31 | 2021-04-02 | 208 | $33.93 | $7.1K | 8,273 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2021-03-04 | 2021-03-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2020-12-31 | 2021-01-04 | 818 | $5.54 | $4.5K | 818 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-12-31 | 2021-01-05 | 222 | $31.80 | $7.1K | 8,065 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2020-09-30 | 2020-10-02 | 624 | $7.26 | $4.5K | 624 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-09-30 | 2020-10-02 | 276 | $25.66 | $7.1K | 7,843 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2020-06-30 | 2020-07-02 | 777 | $5.84 | $4.5K | 777 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-06-30 | 2020-07-02 | 275 | $25.67 | $7.1K | 7,567 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2020-05-28 | 2020-05-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2020-05-27 | 2020-05-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2020-03-31 | 2020-04-02 | 1,294 | $3.50 | $4.5K | 1,294 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2020-03-31 | 2020-04-02 | 460 | $15.37 | $7.1K | 7,292 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2020-03-12 | 2020-03-16 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 20,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 42,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 25,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 50,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer | 2020-01-28 | 2020-01-29 | 40,000 | $6.30 | $252.0K | 0 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-12-31 | 2020-01-03 | 170 | $34.31 | $5.8K | 6,832 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2019-12-18 | 2019-12-19 | 20,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2019-12-18 | 2019-12-19 | 20,000 | $3.28 | $65.6K | 40,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2019-09-30 | 2019-10-02 | 9,845 | $0.46 | $4.5K | 9,845 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-09-30 | 2019-10-02 | 780 | $7.47 | $5.8K | 6,662 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2019-06-28 | 2019-07-02 | 5,096 | $0.89 | $4.5K | 5,096 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-06-28 | 2019-07-02 | 449 | $12.98 | $5.8K | 5,882 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2019-06-25 | 2019-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2019-05-22 | 2019-05-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2019-03-31 | 2019-04-02 | 478 | $12.18 | $5.8K | 5,433 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2019-03-29 | 2019-04-02 | 4,321 | $1.05 | $4.5K | 4,321 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2019-03-14 | 2019-03-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2019-01-23 | 2019-01-25 | 42,000 | — | $0 | 42,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2018-12-31 | 2019-01-03 | 5,924 | $0.76 | $4.5K | 5,924 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-12-31 | 2019-01-03 | 512 | $11.39 | $5.8K | 4,955 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2018-12-14 | 2018-12-18 | 20,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2018-12-14 | 2018-12-18 | 20,000 | $1.05 | $21.0K | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-09-30 | 2018-10-02 | 268 | $21.70 | $5.8K | 4,443 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2018-09-28 | 2018-10-02 | 3,396 | $1.33 | $4.5K | 3,396 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2018-06-29 | 2018-07-03 | 3,464 | $1.31 | $4.5K | 3,464 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-06-29 | 2018-07-03 | 282 | $17.67 | $5.0K | 4,175 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2018-06-18 | 2018-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2018-06-12 | 2018-06-13 | 5,500 | — | $0 | 5,500 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2018-05-23 | 2018-05-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2018-03-30 | 2018-04-03 | 237 | $21.05 | $5.0K | 3,893 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2018-03-29 | 2018-04-02 | 2,860 | $1.58 | $4.5K | 2,860 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2018-03-13 | 2018-03-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-02-09 | 2018-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2017-12-29 | 2018-01-03 | 13,003 | $1.39 | $18.1K | 13,003 | SEC↗ |
| ITCI Intra-Cellular Therapies, | P Buy | 2017-12-29 | 2018-01-03 | 345 | $14.48 | $5.0K | 3,656 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-12-29 | 2018-01-03 | 345 | $14.48 | $5.0K | 3,656 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2017-11-28 | 2017-11-30 | 10,165 | — | $0 | 10,165 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-09-29 | 2017-10-03 | 316 | — | $0 | 3,311 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award | 2017-06-30 | 2017-07-05 | 3,519 | — | $0 | 11,293 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-06-30 | 2017-07-05 | 402 | — | $0 | 2,995 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2017-06-27 | 2017-06-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award deriv | 2017-05-24 | 2017-05-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| YTEN YIELD10 BIOSCIENCE, INC. | A Award | 2017-05-24 | 2017-05-26 | 43,155 | — | $0 | 46,488 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2017-03-31 | 2017-04-04 | 307 | — | $0 | 2,593 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2017-01-19 | 2017-01-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ENUM Enumeral Biomedical Holdin | A Award | 2017-01-03 | 2017-01-05 | 66,666 | — | $0 | 268,121 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-12-30 | 2017-01-03 | 331 | — | $0 | 2,286 | SEC↗ |
| ENUM Enumeral Biomedical Holdin | J Other deriv | 2016-12-09 | 2016-12-13 | 156,000 | $0.13 | $20.3K | 156,000 | SEC↗ |
| ENUM Enumeral Biomedical Holdin | M Exercise deriv | 2016-12-09 | 2016-12-13 | 156,000 | $0.13 | $20.3K | 0 | SEC↗ |
| ENUM Enumeral Biomedical Holdin | P Buy deriv | 2016-12-09 | 2016-12-13 | 39,000 | $0.08 | $3.1K | 39,000 | SEC↗ |
| ENUM Enumeral Biomedical Holdin | M Exercise | 2016-12-09 | 2016-12-13 | 156,000 | $0.13 | $20.3K | 201,455 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-09-30 | 2016-10-04 | 328 | — | $0 | 1,955 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-06-30 | 2016-07-05 | 128 | — | $0 | 1,627 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2016-06-14 | 2016-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2016-03-31 | 2016-04-04 | 134 | — | $0 | 1,499 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2016-01-25 | 2016-01-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ENUM Enumeral Biomedical Holdin | A Award | 2016-01-04 | 2016-01-06 | 45,455 | — | $0 | 45,455 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-12-31 | 2016-01-05 | 69 | $53.79 | $3.7K | 1,365 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-09-30 | 2015-10-02 | 93 | — | $0 | 1,296 | SEC↗ |
| ENUM Enumeral Biomedical Holdin | A Award deriv | 2015-09-22 | 2015-09-24 | 76,000 | — | $0 | 76,000 | SEC↗ |
| MBLX METABOLIX, INC. | A Award | 2015-09-10 | 2015-09-14 | 31,250 | — | $0 | 31,250 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-06-30 | 2015-07-02 | 117 | — | $0 | 1,203 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2015-06-16 | 2015-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2015-03-31 | 2015-04-02 | 157 | — | $0 | 1,086 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2014-12-31 | 2015-01-05 | 212 | — | $0 | 929 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2014-12-02 | 2014-12-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2014-09-30 | 2014-10-02 | 273 | — | $0 | 717 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2014-06-30 | 2014-07-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award | 2014-06-30 | 2014-07-02 | 444 | — | $0 | 444 | SEC↗ |
| MBLX METABOLIX, INC. | A Award deriv | 2014-05-28 | 2014-05-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ITCI Intra-Cellular Therapies, | A Award deriv | 2014-03-21 | 2014-03-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MBLX METABOLIX, INC. | A Award deriv | 2014-01-02 | 2014-01-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MBLX METABOLIX, INC. | A Award deriv | 2014-01-02 | 2014-03-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2013-12-17 | 2013-12-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MBLX METABOLIX, INC. | A Award deriv | 2013-06-06 | 2013-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2012-12-18 | 2012-12-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MBLX METABOLIX, INC. | P Buy | 2012-11-30 | 2012-12-04 | 20,000 | $1.07 | $21.4K | 20,000 | SEC↗ |
| MBLX METABOLIX, INC. | A Award deriv | 2012-06-07 | 2012-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |